Literature DB >> 23896213

Haemorrhagic shock, therapeutic management.

J-S David1, C Spann, G Marcotte, B Reynaud, O Fontaine, M Lefèvre, V Piriou.   

Abstract

The management of a patient in post-traumatic haemorrhagic shock will meet different logics that will apply from the prehospital setting. This implies that the patient has beneficiated from a "Play and Run" prehospital strategy and was sent to a centre adapted to his clinical condition capable of treating all haemorrhagic lesions. The therapeutic goals will be to control the bleeding by early use of tourniquet, pelvic girdle, haemostatic dressing, and after admission to the hospital, the implementation of surgical and/or radiological techniques, but also to address all the factors that will exacerbate bleeding. These factors include hypothermia, acidosis and coagulopathy. The treatment of these contributing factors will be associated to concepts of low-volume resuscitation and permissive hypotension into a strategy called "Damage Control Resuscitation". Thus, the objective in situation of haemorrhagic shock will be to not exceed a systolic blood pressure of 90 mmHg (in the absence of severe head trauma) until haemostasis is achieved.
Copyright © 2013 Société française d’anesthésie et de réanimation (Sfar). Published by Elsevier SAS. All rights reserved.

Entities:  

Keywords:  Damage control; Haemorrhage; Hypotension permissive; Hémorragie; Permissive hypotension; Trauma

Mesh:

Year:  2013        PMID: 23896213     DOI: 10.1016/j.annfar.2013.07.008

Source DB:  PubMed          Journal:  Ann Fr Anesth Reanim        ISSN: 0750-7658


  2 in total

Review 1.  Abdominoplasty: Pitfalls and Prospects.

Authors:  Nayef A Louri; Hamad M Ammar; Fatema Abduljabbar Abdulkariml; Turki Abdulla Sanad Ahmed Eid Alkhaldi; Rashed Noaman AlHasan
Journal:  Obes Surg       Date:  2020-03       Impact factor: 4.129

2.  Managing Complications in Abdominoplasty: A Literature Review.

Authors:  Pedro Vidal; Juan Enrique Berner; Patrick A Will
Journal:  Arch Plast Surg       Date:  2017-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.